Skip to main content

Mitral Valve

  • Chapter
  • First Online:
Catheter Based Valve and Aortic Surgery

Abstract

There are over 210,000 mitral valve operations performed in the United States every year with over 50 % of these patients undergoing mitral valve replacement. Despite shorter durability compared to mechanical valves, bioprosthetic valve usage has continued to rise. This is related to advancements in surgical valve technology, patient preference, and avoidance of long-term anticoagulation [1]. Bioprosthetic structural valve degeneration (SVD) can overtime lead to valvular regurgitation, stenosis, or mixed pathology. It occurs via a variety of mechanisms including leaflet perforation, leaflet tears, commissural tears, cuspal detachment, and restricted leaflet motion. Leaflet dysfunction is most commonly related to collagen degeneration and dystrophic calcification within the bioprosthetic tissue. The true incidence of bioprosthetic valve failure is likely underreported in the published literature and varies greatly between studies. In general, younger patients (less than 65 years of age) have much higher rates of SVD compared to their older counterparts and reoperation more frequently. A number of publications have done subgroup analysis to determine the effect of age at time of surgical mitral valve replacement on the rate of SVD. Table 18.1 shows the differences of published rates of SVD based on age at time of valve implantation. Although older patients have lower rates of SVD compared to their younger counterparts, it still occurs at relatively high frequency. These high rates of SVD in combination with good long-term survival after initial mitral valve surgery has led to increasing numbers of patients requiring reoperations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gammie JS, Sheng S, Griffith BP, et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. 2009;87(5):1431–7.

    Article  PubMed  Google Scholar 

  2. Borger MA, Ivanov J, Armstrong S, Christie-hrybinsky D, Feindel CM, David TE. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis. 2006;15(1):49–55.

    PubMed  Google Scholar 

  3. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36(4):1152–8.

    Article  CAS  PubMed  Google Scholar 

  4. Bourguignon T, Bouquiaux-stablo AL, Loardi C, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014;148(5):2004–2011.e1.

    Article  PubMed  Google Scholar 

  5. Jamieson WR, Von Lipinski O, Miyagishima RT, et al. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement. J Thorac Cardiovasc Surg. 2005;129(6):1301–8.

    Article  CAS  PubMed  Google Scholar 

  6. Ruel M, Chan V, Bédard P, et al. Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults <60 years of age. Circulation. 2007;116(11 Suppl):I294–300.

    PubMed  Google Scholar 

  7. Kaneko T, Aranki S, Javed Q, et al. Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old. J Thorac Cardiovasc Surg. 2014;147(1):117–26.

    Article  PubMed  Google Scholar 

  8. Jamieson WR, Gudas VM, Burr LH, et al. Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement? Eur J Cardiothorac Surg. 2009;35(1):104–10.

    Article  PubMed  Google Scholar 

  9. Mykén PS. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis. J Heart Valve Dis. 2005;14(4):486–92.

    PubMed  Google Scholar 

  10. Chan V, Malas T, Lapierre H, et al. Reoperation of left heart valve bioprostheses according to age at implantation. Circulation. 2011;124(11 Suppl):S75–80.

    Article  PubMed  Google Scholar 

  11. Potter DD, Sundt TM, Zehr KJ, et al. Risk of repeat mitral valve replacement for failed mitral valve prostheses. Ann Thorac Surg. 2004;78(1):67–72.

    Article  PubMed  Google Scholar 

  12. Fukunaga N, Okada Y, Konishi Y, et al. Clinical outcomes of redo valvular operations: a 20-year experience. Ann Thorac Surg. 2012;94(6):2011–6.

    Article  PubMed  Google Scholar 

  13. Jamieson WR, Burr LH, Miyagishima RT, et al. Reoperation for bioprosthetic mitral structural failure: risk assessment. Circulation. 2003;108 Suppl 1:II98–102.

    PubMed  Google Scholar 

  14. Balsam LB, Grossi EA, Greenhouse DG, et al. Reoperative valve surgery in the elderly: predictors of risk and long-term survival. Ann Thorac Surg. 2010;90(4):1195–200.

    Article  PubMed  Google Scholar 

  15. Kirsch M, Nakashima K, Kubota S, Houël R, Hillion ML, Loisance D. The risk of reoperative heart valve procedures in Octogenarian patients. J Heart Valve Dis. 2004;13(6):991–6.

    PubMed  Google Scholar 

  16. Jones JM, O'kane H, Gladstone DJ, et al. Repeat heart valve surgery: risk factors for operative mortality. J Thorac Cardiovasc Surg. 2001;122(5):913–8.

    Article  CAS  PubMed  Google Scholar 

  17. Dvir, D. (2014, September 14th). Perspectives from Valve-in-Valve Experiences. TCT 2014, Washington DC.

    Google Scholar 

  18. Bapat VN, Attia RQ, Condemi F, et al. Fluoroscopic guide to an ideal implant position for Sapien XT and CoreValve during a valve-in-valve procedure. JACC Cardiovasc Interv. 2013;6(11):1186–94.

    Article  PubMed  Google Scholar 

  19. Bapat VN, Attia R, Thomas M. Effect of valve design on the stent internal diameter of a bioprosthetic valve: a concept of true internal diameter and its implications for the valve-in-valve procedure. JACC Cardiovasc Interv. 2014;7(2):115–27.

    Article  PubMed  Google Scholar 

  20. Cullen MW, Cabalka AK, Alli OO, et al. Transvenous, antegrade Melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults. JACC Cardiovasc Interv. 2013;6(6):598–605.

    Article  PubMed  Google Scholar 

  21. Gaia DF, Breda JR, Ferreira CB, De Souza JA, Buffolo E, Palma JH. Double transapical aortic and mitral valve-in-valve implant: an alternative for high risk and multiple reoperative patients. Int J Cardiol. 2013;164(3):e32–4.

    Article  PubMed  Google Scholar 

  22. Gaia DF, Palma JH. De souza JA, et al. Transapical mitral valve-in-valve implant: an alternative for high risk and multiple reoperative rheumatic patients. Int J Cardiol. 2012;154(1):e6–7.

    Article  PubMed  Google Scholar 

  23. Bapat V, Adams B, Attia R, Noorani A, Thomas M. Neo-annulus: A reference plane in a surgical heart valve to facilitate a valve-in-valve procedure. Catheter Cardiovasc Interv. 2014.

    Google Scholar 

  24. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–132.

    Article  PubMed  Google Scholar 

  25. Cheung A, Webb JG, Barbanti M, et al. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol. 2013;61(17):1759–66.

    Article  PubMed  Google Scholar 

  26. Raval J, Nagaraja V, Eslick GD, Denniss AR. Transcatheter valve-in-valve implantation: a systematic review of literature. Heart Lung Circ. 2014;23(11):1020–8.

    Article  PubMed  Google Scholar 

  27. Seeburger J, Borger MA, Falk V, et al. Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients. Eur J Cardiothorac Surg. 2008;34(4):760–5.

    Article  PubMed  Google Scholar 

  28. David TE, Armstrong S, Mccrindle BW, Manlhiot C. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation. 2013;127(14):1485–92.

    Article  PubMed  Google Scholar 

  29. Flameng W, Herijgers P, Bogaerts K. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation. 2003;107(12):1609–13.

    Article  PubMed  Google Scholar 

  30. De Weger A, Ewe SH, Delgado V, Bax JJ. First-in-man implantation of a trans-catheter aortic valve in a mitral annuloplasty ring: novel treatment modality for failed mitral valve repair. Eur J Cardiothorac Surg. 2011;39(6):1054–6.

    Article  PubMed  Google Scholar 

  31. Descoutures F, Himbert D, Maisano F, et al. Transcatheter valve-in-ring implantation after failure of surgical mitral repair. Eur J Cardiothorac Surg. 2013;44(1):e8–15.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Evelio Rodriguez MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Morse, M.A., Meece, R., Rodriguez, E. (2016). Mitral Valve. In: Ailawadi, G., Kron, I. (eds) Catheter Based Valve and Aortic Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3432-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3432-4_18

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3430-0

  • Online ISBN: 978-1-4939-3432-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics